Lyophilized Recombinant Human Brain Natriuretic Peptide - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241615

Publication Date:

September 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Lyophilized Recombinant Human Brain Natriuretic Peptide is indicated for the intravenous treatment of patients with acute decompensated heart failure who have dyspnea at rest or with mild activity.
The global market for Lyophilized Recombinant Human Brain Natriuretic Peptide was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Lyophilized Recombinant Human Brain Natriuretic Peptide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lyophilized Recombinant Human Brain Natriuretic Peptide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Lyophilized Recombinant Human Brain Natriuretic Peptide was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Lyophilized Recombinant Human Brain Natriuretic Peptide include Novartis and Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lyophilized Recombinant Human Brain Natriuretic Peptide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lyophilized Recombinant Human Brain Natriuretic Peptide by region & country, by Type, and by Application.
The Lyophilized Recombinant Human Brain Natriuretic Peptide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized Recombinant Human Brain Natriuretic Peptide.
麻豆原创 Segmentation
By Company
Novartis
Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.
Segment by Type:
0.5mg
1.5mg
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lyophilized Recombinant Human Brain Natriuretic Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lyophilized Recombinant Human Brain Natriuretic Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lyophilized Recombinant Human Brain Natriuretic Peptide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Product Introduction
1.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Size Forecast
1.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value (2019-2030)
1.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume (2019-2030)
1.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Price (2019-2030)
1.3 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Trends & Drivers
1.3.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Industry Trends
1.3.2 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Drivers & Opportunity
1.3.3 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Challenges
1.3.4 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Players Revenue Ranking (2023)
2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue by Company (2019-2024)
2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Players Sales Volume Ranking (2023)
2.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Company Players (2019-2024)
2.5 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price by Company (2019-2024)
2.6 Key Manufacturers Lyophilized Recombinant Human Brain Natriuretic Peptide Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Lyophilized Recombinant Human Brain Natriuretic Peptide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Lyophilized Recombinant Human Brain Natriuretic Peptide
2.9 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Competitive Analysis
2.9.1 Lyophilized Recombinant Human Brain Natriuretic Peptide 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Lyophilized Recombinant Human Brain Natriuretic Peptide Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized Recombinant Human Brain Natriuretic Peptide as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 0.5mg
3.1.2 1.5mg
3.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type
3.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, by Type (2019-2030)
3.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, by Type (%) (2019-2030)
3.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Type
3.3.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume, by Type (2019-2030)
3.3.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume, by Type (%) (2019-2030)
3.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Child
4.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application
4.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, by Application (2019-2030)
4.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, by Application (%) (2019-2030)
4.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Application
4.3.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume, by Application (2019-2030)
4.3.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume, by Application (%) (2019-2030)
4.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Region
5.1.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Region (2019-2024)
5.1.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Region (2025-2030)
5.1.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Region (%), (2019-2030)
5.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Region
5.2.1 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Region (2019-2024)
5.2.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Region (2025-2030)
5.2.4 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume by Region (%), (2019-2030)
5.3 Global Lyophilized Recombinant Human Brain Natriuretic Peptide Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
5.4.2 North America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
5.5.2 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
5.6.2 Asia Pacific Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
5.7.2 South America Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
5.8.2 Middle East & Africa Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value
6.2.1 Key Countries/Regions Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.2.2 Key Countries/Regions Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.3.2 United States Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.4.2 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.5.2 China Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.5.3 China Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.6.2 Japan Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.7.2 South Korea Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.8.2 Southeast Asia Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value, 2019-2030
6.9.2 India Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Type (%), 2023 VS 2030
6.9.3 India Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis Lyophilized Recombinant Human Brain Natriuretic Peptide Product Offerings
7.1.5 Novartis Recent Development
7.2 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.
7.2.1 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Company Information
7.2.2 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Introduction and Business Overview
7.2.3 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Lyophilized Recombinant Human Brain Natriuretic Peptide Product Offerings
7.2.5 Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Industrial Chain
8.2 Lyophilized Recombinant Human Brain Natriuretic Peptide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Lyophilized Recombinant Human Brain Natriuretic Peptide Sales Model
8.5.2 Sales Channel
8.5.3 Lyophilized Recombinant Human Brain Natriuretic Peptide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Novartis
Chengdu Rhodiola Bio-Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.